Financial statements review 2025 published

"Valmet operates at the heart of two global transformations: advancing circularity and unlocking resource efficiency. Our strategy, Lead the Way, sharpens our focus on these themes with a clear purpose: Transforming industries towards a regenerative tomorrow.

With 35–50% market share in key biomaterial process technologies, Valmet has built one of the largest installed bases in the industry — a structural advantage that drives recurring revenues and long-term customer relationships. As one of the leading service partners globally, we support customers across the lifecycle from initial delivery through decades of operation.

We see structural growth opportunities in both segments. In Biomaterial Solutions and Services, we aim to double our organic services growth to 8% and raise market share to 25% by 2030. In Process Performance Solutions, we deliver mission-critical technologies that improve resource efficiency, reduce emissions, and support customers’ core operations. Our target is to grow organically at more than twice the market rate.

These ambitions are backed by strong fundamentals, a streamlined operating model, and a clear 2030 financial framework: 5% organic growth, 15% comparable EBITA margin, and 20% ROCE.

Read more about the reasons to invest in Valmet in our comprehensive investor website and remember to subscribe to our IR newsletter and follow us on social media platform X @ValmetIR." You can read more about Valmet as a company here.

- Pekka Rouhiainen, VP, Investor Relations